Jurai Wongsawat, M'D' - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Jurai Wongsawat, M'D'

Description:

Hardiest non spore forming bacteria. Relatively heat resistance ... persistent nasal carriage. Nasal screening - endemic with serious infection - outbreak ... – PowerPoint PPT presentation

Number of Views:22
Avg rating:3.0/5.0
Slides: 27
Provided by: LeK
Category:

less

Transcript and Presenter's Notes

Title: Jurai Wongsawat, M'D'


1
MRSA Infection control outbreak investigation
  • Jurai Wongsawat, M.D.
  • Bamrasnaradura Institute
  • Nonthaburi, Thailand

2
Outlines
  • Mechanism of transmission
  • Prevention Control
  • Outbreak investigation

3
Staphylococci
  • Hardiest non spore forming bacteria
  • Relatively heat resistance
  • Can survive in environmental for several months
  • Children and adult up to 25 can be colonized

4
High risk - Colonization
  • HOST
  • Hemodialysis/ CAPD
  • Injection drug users
  • Dermatologic diseases
  • DM
  • Those who required repeated injections
  • Liver disease
  • HIV or other defect immune function
  • Nasal abnormalities
  • OTHER FACTORS
  • Presence of invasive device
  • Prior antimicrobial therapy
  • History of antecedent colonization
  • Increase chance of exposure - HCWs

5
Modes of transmission
  • Mainly via direct contact
  • - hands of HCWs
  • Indirect contact
  • - clothes, environmental surface,
    equipment
  • Airborne transmission
  • - Staph pneumonia

6
Special problems
  • Epidemic vs endemic MRSA
  • Community acquired
  • - skin and soft tissue infection
  • - positive culture on admission
  • or within 48 hours
  • Frequent antibiotic use

7
Problem of ATB use
  • Reducing use of second or third gen.
    cephalosporin can reduce rate of colonization/
    infection
  • ( Matsumara H, et al. Burns 199622283-6)
  • Reduction use of many broad spectrum B-lactam ATB
    was associated with drop of MRSA cases
  • ( Frank, et al. Clin Perform qual Health Care
    19975180-88)
  • Significant reduction in monthly number of MRSA
    following decreased use of cephalosporin,
    imipenam, clindamycin, vancomycin
  • ( Landman D, et al. Clin Infect Dis
    1999281062-66)

8
Outlines
  • Mechanism of transmission
  • Prevention Control
  • Outbreak investigation

9
Prevention
Control
  • Administrative
  • - Surveillance
  • - Hand hygiene policy
  • - Antibiotic control program
  • Engineering
  • - Isolation room
  • Protective equipments
  • - Gown, gloves, mask
  • Surveillance
  • Isolation or cohort nursing Encourage for hand
    hygiene
  • Management of colonizers or carriers
  • Tretment of infected patients

10
Advocated measures (1)
11
Advocated measures (2)
12
Surveillance
  • Laboratory based
  • Line listing of MRSA cases
  • Routine screening in patients is not recommended
  • Screening for high risk patients
  • Screen known cases upon readmission

13
Isolation or cohort nursing
  • Contact precaution
  • Isolation
  • - not necessary if routine standard
    practice is in place
  • - necessary for
  • MRSA respiratory tract infections
  • wounds that cannot be
  • adequately covered

14
Hand hygiene (1)
  • The most important measure
  • Transmission decreased from 16.9 to 9.9 ( 2.16
    to 0.93 episodes per 10,000 patient days)
  • when hand hygiene improved from 48 to 66 (
    Pittet et al)
  • Problem low adherence

15
Hand hygiene (2)
  • The most important measure
  • Transmission decreased from 16.9 to 9.9 ( 2.16
    to 0.93 episodes per 10,000 patient days)
  • when hand hygiene improved from 48 to 66 (
    Pittet et al)
  • Problem low adherence

16
Hand hygiene (3)
  • A simple 10 second wash with soap and water shows
    an absence of MRSA on 96 of cultured individuals
    hand (Simmons B, et al)
  • Alcohol based hand rub
  • - increase compliance

17
Management of colonizers or carriers
  • Consider during the outbreak
  • More likely to transmitt
  • - skin lesion/dermatitis
  • - persistent nasal carriage
  • Nasal screening
  • - endemic with serious infection
  • - outbreak

18
Decolonization
  • 2 mupirocin intranasal
  • Rifampin 600 mg bid for 5 days
  • Ciprofloxacin 750 mg bid for 14 days
  • Combination drug
  • High rate of recurrence at 1 mo

19
Treatment of infected patients
  • Parenteral glycopeptide therapy
  • Serum concentration should be monitored

20
Outlines
  • Mechanism of transmission
  • Prevention Control
  • Outbreak investigation

21
Approach
  • Surveillance
  • problem, cluster
  • Determine existence of an outbreak
  • - define case, compare preepidemic
  • Epidemiologic study
  • - line listing, epidemic curve, risk factor
    study
  • ( case control/ cohort)
  • Additional studies
  • - reviews, culture surveys, isolate typing
  • Interventions/ control measures
  • Assess interventions

22
Elimination of Epidemic MRSA from a University
Hospital and District Institutions, Finland
  • August 1991 October 1992, two outbreaks in
    surgery medicine
  • Screening policy after cases occurred
  • - all pts, contact HCWs
  • - nasal swab other sites
  • after 2 neg results individuals were no
    longer screened
  • Subsequent admission
  • - screen and isolate

Kotilainen P, et al. Emerg Infect Dis 20039
169 -75)
23
Elimination of Epidemic MRSA from a University
Hospital and District Institutions, Finland
  • Identification
  • - NCCLS
  • - Typed with
  • International phage set ( Phage typing)
  • pulsed field gel electrophoresis
  • ( PFGE - molecular typing)
  • Elimination treatment
  • Topical or combined high risks gr.

Kotilainen P, et al. Emerg Infect Dis 20039
169 -75)
24
Elimination of Epidemic MRSA from a University
Hospital and District Institutions, Finland
  • Results
  • 202 were infected/ colonized
  • 15 strains - 10 outbreak strains
  • - 5 community strains
  • IC measures
  • - Intensive education of staff on hospital
    hygiene
  • - single room isolation
  • - strict adherence
  • - screening all patients in outbreak ward
  • - closed to new admission ( epidemic)
  • 20 staff members were colonized

Kotilainen P, et al. Emerg Infect Dis 20039
169 -75)
25
Conclusion
  • Aware of high risk patients
  • Early identification
  • Proper infection control measures
  • Good surveillance systems
  • Proper use of antibiotics

26
Thank you
Write a Comment
User Comments (0)
About PowerShow.com